Clinical Trials Arena April 14, 2025
With trial costs rising over the past decade and concerns they’ll keep climbing, companies are seeking ways to manage expenses.
Clinical trial costs have been rising year-on-year, with companies working to balance the scales and keep studies running despite declining investment.
The pharma and biotech sector appeared to be jumping into action during the 2021 financial boom, however, this was followed by a drought of financing in the three years since. At the same time, costs have been rising for research, meaning companies who are yet to market a product are caught in the middle of a perfect storm.
GlobalData research, using its proprietary Trial Cost Estimates model, shows the cost to run single-country and multi-country trials has risen annually...
Today's Sponsors
Today's Sponsor